hsa-mir-1181: Hsa-mir-1181 is an upregulated miRNA found in semen samples, and it is associated with the prolactin signaling pathway [PMC10051987]. A study identified ten miRNAs in semen samples, including hsa-mir-1181, and three miRNAs in urine samples [PMC10051987]. However, hsa-mir-1181 was eliminated from further analysis [PMC3117799]. It was found that hsa-mir-1181 and other miRNAs had 3n motifs in their sequences, except for a few exceptions like hsa-mir-122 [PMC9316571]. A single nucleotide polymorphism (SNP) in the seed region of hsa-mir-1181 could potentially affect the regulation of target genes [PMC7778889]. Hsa-mir-1181 was significantly enriched among driver candidates but had a limited number of target genes [PMC9379253]. In patients with gallbladder cancer (GBC), hsa-miR-142-5p and hsa-miR-146b-5 were exclusively downregulated in those with long-term survival, while several other miRNAs including hsa-miR-4462 were exclusively observed in patients with short-term survival [PMC7238852]. Hsa-miR-3610 and other miRNAs except for hsa-mir 1181 had biological targets [PMC7238852]. HSA-MIR 1181 was among the 22 miRNAs that showed promise for classification purposes based on their expression levels [PMC7990312]. It was found that HSA-MIR 1181 targeted multiple transcripts from a set of network-central predictor genes except for SFXN2 [PMC6686563]. Additionally, HSA-MIR 1181 was found to be related to the formative process of liver cancer [PMC7355149].